Management of Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine Pericardial Xenografts

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05777681

Enrollment

Registered

2023-03-21

Start date

2022-10-01

Completion date

2026-11-01

Last updated

2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Diseases

Brief summary

Aortic infections (AIs), including aortic graft infections (AGI) as well as mycotic aortic aneurysms (MAA), are rare. The aim of this study is to present our experience with xenogeneic aortic and aortoiliac reconstructions using the BioIntegral Surgical No-React® bovine pericardial graft.

Interventions

PROCEDUREAortic Surgery

open surgical repair with resection of infected aortic segment, debridement of surrounding tissue and in situ graft replacement.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Aortic infection * Mycotic Aneurysm * Aortic Graft Infection

Exclusion criteria

* Absence of signs of infection

Design outcomes

Primary

Measure	Time frame	Description
Early Mortality	30 days	Mortality 30 days after the procedure

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026